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Abstract: The Amaryllidaceae family is well known for the presence of an exclusive 
group of alkaloids with a wide range of biological activities. Narcissus serotinus L. is a 
plant belonging to this family and its geographical distribution is mainly located along the 
Mediterranean coast. In the present work, specimens collected near Casablanca (Morocco) 
were used to study the alkaloid content of this species. Starting with 350 g of the whole 
plant we used standard extraction and purification procedures to obtain fractions and 
compounds for GC-MS and NMR analysis. As well as five known alkaloids, we isolated 
two new compounds: 1-O-(3´-acetoxybutanoyl)lycorine and narseronine. The latter has 
been previously published, but with an erroneous structure. 
Keywords: Narcissus serotinus; Amaryllidaceae; alkaloids; narseronine; 1-O-(3´-acetoxy-
butanoyl)lycorine 
 
1. Introduction 
Plants belonging to the Amaryllidaceae family are well known for the presence of an exclusive 
group of alkaloids with a wide range of biological activities [1]. Within this group, the genus 
Narcissus has been extensively used in traditional medicine to treat a variety of health problems. 
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Antiviral, antifungal and antitumoral activities are just some of the phamacological effects that have 
been proven for these alkaloids. 
Narcissus serotinus L. is an autumn flowering species and the only member of the monotypic 
section Serotini. It grows mostly in calcareous sandy soil or maquis in dry coastal areas, and its 
geographical distribution extends over the coastal southern Mediterranean region, including southern 
Portugal, southern and eastern Spain, western and eastern Italy, Croatia, much of Greece and Israel, 
almost all the Mediterranean islands, north-west Morocco, Algeria, Tunisia and Libya [2,3]. 
The aim of this work is to investigate the alkaloid content of this species through the analysis of 
specimens collected in Morocco. In a previously published article, Vrondeli et al. [4] described the 
isolation of a new alkaloid from this species, suggesting a 3-epimacronine isomer. Based on the results 
reported herein, we propose an alternative structure, which also represents a new compound within the 
Amaryllidaceae alkaloid family. 
2. Results and Discussion 
The MeOH extract of the fresh aerial parts and bulbs of N. serotinus L. was fractioned according to 
the methodology described in the experimental section. The GC-MS analysis of fraction B revealed the 
presence of lycorine. The analysis of fraction A showed a more complex mixture: in addition to 
lycorine [1,5] we determined the presence of galanthine [1,6], 1-O-(3´-hydroxybutanoyl)lycorine [7], 
assoanine [8] and hippeastrine [9] together with two new alkaloids (Figure 1). Identification of known 
compounds and structural elucidation of the new ones were achieved through the combined use of  
GC-MS, HRMS and one and two-dimensional NMR techniques. 
The HRMS of 1 suggested a molecular formula C22H26NO7 for [MH]+ with a parent ion at m/z 
416.1702 (calc. 416.1704). The EIMS showed a molecular ion [M]+ at m/z 415 (18%) with a base peak 
at m/z 226. It is interesting to note that the isomer 2-O-(3´-acetoxybutanoyl)lycorine, isolated from 
Galanthus nivalis [10], shows a very similar fragmentation pattern but with a base peak at m/z 250. 
However, the pattern observed for 1 shows the base peak at m/z 226 [7]. These empirical cases prove 
that the GC-MS technique is useful for differentiating between isomers with substituents at position 1 
or 2. The 1H-NMR spectral data of compound 1 and the isomer, 2-O-(3´-acetoxybutanoyl)lycorine, are 
very similar too, showing the major difference in proton shielding at positions 1 and 2: in 1 H-1 is 
more deshielded (δ 5.68) than the same proton in the isomer (δ 4.51) and the inverse situation occurs 
for H-2, which appears at δ 4.23 in the spectrum of 1 and at δ 5.31 for the isomer. Considering its 
coupling constant values, we assume that the configuration of 1 is the same as that proposed for 2-O-
(3´-acetoxybutanoyl)lycorine and 1-O-(3´-hydroxybutanoyl)lycorine. The high coupling constant 
(10.4) observed between H-4a and H-10b suggests a trans-diaxial configuration. Protons 6β and 12β 
are more deshielded than 6α and 12α, respectively, because of the cis-lone pair of the nitrogen atom. 
The combined data suggested for compound 1 the structure of 1-O-(3´-acetoxybutanoyl)lycorine. The 
1H-NMR, COSY and HSQC data are recorded in Table 1.  
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Figure 1. New alkaloids isolated from N. serotinus L. 1-O-(3´-acetoxybutanoyl)lycorine 
(1) and narseronine (2). 
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Table 1. 1H-NMR, COSY and HSQC data of 1-O-(3´-acetoxybutanoyl)lycorine (1). 
Position 1H δ (J in Hz) COSY HSQC 
1 5.68 s H-2, H-10b 72.5 d 
2 4.23 dt (3.3, 1.7) H-1, H-3, H-11 69.4 d 
3 5.56 m H-2, H-11 116.9 d 
4a 2.76 d (10.4) H-10b 61.9 d 
6α 3.54 d (14.1) H-6β 56.6 t 
6β 4.16 d (14.1) H-6α 56.6 t 
7 6.58 s  107.3 d 
10 6.72 s  104.8 d 
10b 2.91 d (10.4) H-1, H-4a 38.8 d 
11 (2H) 2.65 m H-2, H-3, H-12α, H-12β 28.4 t 
12α 2.42 dd (9.3, 5.0) H-11, H-12β 53.4 t 
12β 3.38 dt (9.2, 4.8) H-11, H-12α 53.4 t 
OCH2O 5.92 s  100.8 t 
2´A 2.43 dd (15.5, 5.4)   H-2´B, H-3´ 40.5 t 
2´B 2.53 dd (15.5, 7.8) H-2´A, H-3´ 40.5 t 
3´ 5.10 m H-2´A, H-2´B, H-4´ 66.9 d 
4´  1.14 d (6.3) H-3´ 19.3 q 
AcO (2´´) 1.95 s   20.7 q 
 
The HRMS analysis of narseronine (2) suggested a molecular formula C18H20NO5 for the parent ion 
[M+H]+ at m/z 330.1340 (calc. 330.1336). This indicates a molecular formula C18H19NO5, in 
accordance with a molecular weight of 329. The EIMS showed a molecular ion [M]+ at m/z 329 (20%). 
The mass spectral fragmentation pattern is not similar to those commonly shown by the homolycorine 
type compounds, because of the absence of a double bond between C-3 and C-4. The unusual 
occurence of a double bond at position C-1/C-10b probably drastically changes this pattern. Its 1H 
NMR spectrum exhibited two singlets at δ 7.66 and 7.29 for the para-oriented aromatic prontons H-7 
and H-10, respectively, with H-7 more deshielded due to the peri-carbonyl group [1]. Also, the 
NOESY experiment showed the spatial proximity between H-10 and the N-methyl group. Two 
doublets appeared at δ 6.10 and δ 6.12 for the protons of the methylendioxy group. A triplet at δ 4.22 
was assigned to H-2, coupled to H-3 with a J = 6.1 Hz, suggesting an equatorial orientation with a 
similar dihedral angle between H-2 and the two H-3 protons; this is consistent with the α position of 
the methoxy group at C-2 and with the NOESY correlation of this substituent with H-11. A doublet at 
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δ 3.94, was undoubtedly assigned to H-4a for a 3JC-H HMBC correlation with the N-methyl group; 
COSY experiment showed its only correlation with H-4, with a J = 6.4 Hz suggesting a cis- C/D ring 
fusion [11,12]. The spectrum also showed, between the most significant signals, a singlet integrating 
for 3 protons at δ 3.57 assigned to the methoxy group at C-2, a doublet of triplets at δ 3.05, assigned to 
H-12α, more deshielded than H-12β because of the cis-lone pair of the nitrogen atom [1], a singlet 
corresponding to the N-methyl group at δ 2.41, also supporting the cis-C/D ring junction if we consider 
the empirical correlations of N-methyl chemical shifts with stereochemical assignments suggested by 
Jeffs et al. [11]; and a doublet of triplets at δ 2.01 assigned to H-3α, showing spatial proximity with the 
O-CH3 group in the NOESY experiment. The NMR spectral data is shown in Table 2. 
Narseronine was previously isolated by Vrondeli et al. [4] but published with an erroneous 
structure. They suggested a 3-epimacronine isomer, a tazettine type alkaloid but their mass spectral 
fragmentation proposal does not explain the occurrence of the most abundant peaks of the mass 
spectrum, such as m/z 240 or 241. Also, the 1H-NMR assignment is not adequate, including, for 
instance, the protons in an α-position to the N-methyl group (H-6 in their numbering system) at δ  
2.30-1.80 ppm, a more shielded displacement than can be expected for a proton in such an  
electronic environment. 
Table 2. 1H-NMR, COSY, NOESY, 13C-NMR (HSQC) and HMBC data of narseronine (2). 
Position 1H δ (J in Hz) COSY NOESY 13C δ HMBC 
1 - - - 152.9 s - 
2 4.22 t (6.1) H-3α, H-3β H-3α, H-3β, OCH3 74.9 d C-1, C-3, C-4,  
C-10b, OCH3 
3α 2.01 dt  
(13.5, 5.5) 
H-2, H-3β, H-4 H-2, H-3β, H-4, 
OCH3 
31.4 t C-1, C-2, C-4, C-4a,  
C-11 
3β 2.22 - 2.13 m 
(overlapped) 
H-2, H-3α, H-4 H-2, H-3α, H-4, 
OCH3 
31.4 t C-1, C-2, C-4, C-4a,  
C-11 
4 2.64 m H-3α, H-3β, H-4a, 
H-11α, H-11β 
H-3α, H-3β, H-4a,  
H-11α, H-11β 
35.1 d C-12 
4a 3.94 d (6.4) H-4 H-4, H-10, NCH3 61.6 d C-1, C-3, C-4, C-10a, C-
10b, C-11, C-12, NCH3 
6 - - - 161.5 s - 
6a - - - 116.4 s - 
7 7.66 s - - 107.8 d C-6, C-8, C-9, C-10a 
8 - - - 148.4 s - 
9 - - - 153.8 s - 
10 7.29 s - H-4a, NCH3 103.3 d C-6a, C-8, C-9, C-10b 
10a - - - 135.1 s - 
10b - - - 110.8 s - 
11α 2.22 - 2.13 m 
(overlapped) 
H-4, H-11β,  
H-12α, H-12β 
H-4, H-11β,  H-12α, 
H-12β, OCH3 
29.6 t C-3, C-4a 
11β 1.90 ddd  
(12.6, 8.3, 4.2) 
H-4, H-11α,  
H-12α, H-12β 
H-4, H-11α,  H-12α, 
H-12β, OCH3 
29.6 t C-3, C-4a 
12α 3.05 dt  
(11.0, 7.6) 
H-11α, H-11β,  
H-12β 
H-11α, H-11β,  
H-12β, NCH3 
54.3 t C-4, C-4a, C-11, NCH3 
12β 2.81 m H-11α, H-11β,  
H-12α 
H-11α, H-11β,  
H-12α, NCH3 
54.3 t C-4, C-4a, C-11, NCH3 
OCH2O 6.10 d (1.2)  
6.12 d (1.2) 
- - 102.4 t C-8, C-9 
OCH3 3.57 s - H-2, H-3α, H-3β,  
H-11α, H-11β 
58.3 q C-2 
NCH3 2.41 s - H-2, H-3α, H-3β,  
H-11α, H-11β 
41.8 q C-4a, C-12 
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3. Experimental  
3.1. General 
NMR spectra were recorded in a Mercury 400 MHz or a Varian VXR 500 MHz, instrument using 
CDCl3 as the solvent and TMS as the internal standard. Chemical shifts were reported in δ units (ppm) 
and coupling constants (J) in Hz. EIMS were obtained on a GC-MS Agilent 6890 + MSD 5975 
operating in EI mode at 70 eV. A HP-5 MS column (30 m × 0.25 mm × 0.25 μm) was used. The 
temperature program was: 100-180 ºC at 15 ºC min-1, 1 min hold at 180 ºC, 180-300 ºC at 5 ºC min-1 
and 1 min hold at 300 ºC. Injector temperature was 280 ºC. The flow rate of carrier gas (Helium) was 
0.8 mL min-1. In most cases the split ratio was 1:20, but with more diluted samples a split ratio of 1:5 
was applied. UV spectra were obtained on a DINKO UV2310 instrument and IR spectra were recorded 
on a Nicolet Avatar 320 FT-IR spectrophotometer. 
3.2. Plant material 
Whole plants of Narcissus serotinus L. (Amaryllidaceae) were collected in October 2009 during the 
flowering period in Ben Slimane, near Casablanca (Morocco), and identified by Professor El Ghazi. A 
voucher sample (MB-026/2009) was deposited at the Herbarium of the Faculty of Sciences Ain Chock, 
University Hassan II. 
3.3. Extraction and isolation of alkaloids 
The fresh whole plant (350 g) was crushed and extracted with methanol (1 × 800 mL, 24 h;  
1 × 800 mL, 72 h; and 2 × 400 mL, 48 h each). The extract was evaporated under reduced pressure to 
yield 5.5 g. This crude extract was dissolved in 100 mL of H2SO4 1% (v/v) and neutral material was 
removed with Et2O (6 × 100 mL). The acidic soln. was basified with 25% ammonia up to pH 9-10 and 
extracted with EtOAc (3 × 100 mL) to give extract A (149.4 mg). Another extraction with EtOAc  
(2 × 100 ml) gave extract B (23 mg). Both fractions were dried with anhydrous Na2SO4, filtered and 
completely dried under reduced pressure. Referred to the fresh weight, the sum of these two extracts 
represents approximately 0.05%. After dissolving A and B in MeOH, lycorine crystallized directly. 
Extract A was subjected to a vacuum liquid chromatography (VLC) [13] using a silica gel 60 A  
(6-35 μ) column with a diameter of 1 cm and a height of 4 cm. Alkaloids were eluted using hexane 
gradually enriched with EtOAc, and then EtOAc gradually enriched with MeOH. Fractions of 10 mL 
were collected (105 in total) monitored by TLC (Dragendorff´s reagent, UV 254 nm) and combined 
according to their profiles. Five main fractions were obtained and subjected to preparative TLC (20 cm 
× 20 cm × 0.25 mm, silica gel 60F254). Narseronine (2, 4.5 mg) and 1-O-(3´-acetoxybutanoyl)lycorine 
(1, 1.5 mg) were obtained in major quantities from fractions 32-38 (eluted from VLC with hexane-
EtOAc, 30:70 to 20:80) through preparative TLC (EtOAc-hexane 4:1 + 25% ammonia). 
 
1-O-(3´-Acetoxybutanoyl)lycorine (1). UV (MeOH) λmax nm: 368.0, 260.0. IR (CHCl3) νmax cm-1: 
2959, 2924, 2853, 1735, 1461, 1371, 1244, 1170, 1038, 776. 1H-NMR, COSY, HSQC (400 MHz, 500 
MHz, CDCl3) see Table 1. EIMS 70eV (rel. int.): 416 (4), 415 (18), 354 (1), 269 (12), 268 (37), 250 
Molecules 2010, 15 7088
(27), 227 (75), 226 (100), 192 (4), 147 (5), 96 (4), 69 (15), 43 (27). HRMS of [M+H]+ m/z 416.1702 
(Calc. 416.1704 for C22H26NO7).  
 
Narseronine (2). UV (MeOH) λmax nm: 322.5, 286.0, 241.5. IR (CHCl3) νmax cm-1: 2928, 1718, 1503, 
1482, 1415, 1283, 1256, 1162, 1106, 1035, 935, 754. 1H-NMR, COSY, NOESY, HSQC, HMBC and 
13C-NMR (500 MHz, CDCl3) see Table 2. EI-MS 70eV (rel. int.): 329 (20), 328 (21), 314 (2), 299 
(28), 272 (38), 271 (18), 256 (46), 255 (16), 254 (30), 242 (34), 241 (98), 240 (100), 228 (13), 213 
(18), 212 (13), 59 (42), 57 (60), 44 (37). HRMS of [M+H]+ m/z 330.1340 (Calc. 330.1336 for 
C18H20NO5).  
4. Conclusions 
These results lead us to conclude that N. serotinus L. is an interesting source of alkaloids with 
potential pharmacological activities. Lycorine type alkaloids have shown notable properties as potent 
antimalarial and antitrypanosomal agents [7]. Recent investigations, including structure-activity 
studies, have also demonstrated they are potent inducers of apoptosis with good antitumoral activities 
[5,14]. In this sense, 1-O-(3´-acetoxybutanoyl)lycorine (1) is an attractive candidate for research in 
these areas. The isolation of narseronine (2) is also promising; this is the first report of a double bond 
between C-1 and C-10b in a homolycorine type structure, a feature that confers rigidity to the portion 
of the molecule formed by A-B rings, and also has a stabilising effect due to the extended conjugated 
system. This could be an interesting characteristic for potential biological activities related with 
pharmocophores with such requirements. In other respects, previous reports of antifungal activity of 
homolycorine-related structures such as hippeastrine [15], suggest narseronine has potential activity as 
an antifungal agent. 
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